Literature DB >> 23017230

Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis.

Wei Nie1, Zheng Fang, Bing Li, Qing-yu Xiu.   

Abstract

Several studies assessed the associations of interleukin-10 (IL-10) polymorphisms with asthma in different populations. However, the results were inconclusive. The aim of the present study was to further assess the associations by the method of meta-analysis. Pubmed, EMBASE, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Weipu Database were searched. Data were extracted independently by two authors. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Seventeen potentially eligible articles were identified (4478 cases and 4803 controls). Significant associations between -1082A/G and -592A/C polymorphisms and asthma were observed. However, there was no significant association between -819T/C polymorphism and asthma risk. In addition, there were significant associations of the IL-10 haplotypes with asthma. In summary, this meta-analysis suggested that IL-10 promoter polymorphisms were associated with asthma risk.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017230     DOI: 10.1016/j.cyto.2012.08.023

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  18 in total

1.  Interleukin-6 -634C/G polymorphism is associated with lung cancer risk: a meta-analysis.

Authors:  Wei Nie; Lei Xue; Guangyuan Sun; Ye Ning; Xuewei Zhao
Journal:  Tumour Biol       Date:  2014-01-10

2.  IL-10 and IL-17F Promoter Single Nucleotide Polymorphism and Asthma: A Case-Control Study in South India.

Authors:  Sareh Raeiszadeh Jahromi; P A Mahesh; B S Jayaraj; Amrutha D Holla; Sangeetha Vishweswaraiah; Nallur B Ramachandra
Journal:  Lung       Date:  2015-06-25       Impact factor: 2.584

3.  Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis.

Authors:  Annukka Holster; Johanna Teräsjärvi; Juho Vuononvirta; Petri Koponen; Ville Peltola; Merja Helminen; Qiushui He; Matti Korppi; Kirsi Nuolivirta
Journal:  World J Pediatr       Date:  2018-05-25       Impact factor: 2.764

4.  Tumor-derived MDSCs inhibit airway remodeling in asthmatic mice through regulating IL-10 and IL-12.

Authors:  Yanli Zhang; Boyi Xu; Bin Luan; Yan Zhang; Xiufang Wang; Xiaorong Xiong; Hongke Shi
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 5.  Interleukin-10 Gene Promoter Polymorphisms and Susceptibility to Asthma: Systematic Review and Meta-analysis.

Authors:  Danyal Imani; Navid Dashti; Arash Parvari; Sajad Shafiekhani; Fatemeh Alebrahim; Bahman Razi; Masoud Hassanzadeh Makoui; Morteza Motallebnezhad; Saeed Aslani; Mansur Aliyu
Journal:  Biochem Genet       Date:  2021-03-23       Impact factor: 1.890

6.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.

Authors:  Luqian Zhao; Ping Huang
Journal:  Int J Clin Exp Med       Date:  2013-09-01

Review 7.  Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis.

Authors:  Xue-yan Zheng; Wei-jie Guan; Chen Mao; Hui-fang Chen; Hong Ding; Jin-ping Zheng; Ting-ting Hu; Min-hong Luo; Yan-hui Huang; Qing Chen
Journal:  Lung       Date:  2013-10-27       Impact factor: 2.584

8.  Effects of polymorphisms -1112C/T and +2044A/G in interleukin-13 gene on asthma risk: a meta-analysis.

Authors:  Wei Nie; Yongan Liu; Jiarong Bian; Bin Li; Qingyu Xiu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Interleukin-13 +1923C/T polymorphism is associated with asthma risk: a meta-analysis.

Authors:  Yongan Liu; Tao Liu; Wei Nie; Guoxiang Lai; Qingyu Xiu
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

10.  Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.

Authors:  Li Li; Wei Nie; Hongfeng Zhou; Weifeng Yuan; Weifeng Li; Wenjie Huang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.